 |
 |
 |
|
 | |||||
| |||||||||
 | |||||||||
|
|
 |
|
|
Direct-To-Consumer
Promotion: Public Meeting The Food and Drug Administration (FDA) will hold a public meeting regarding direct-to-consumer (DTC) promotion of prescription drugs. The purpose of the meeting is for FDA and other persons and organizations to present the results of research on the promotion of prescription drug products directly to consumers through print, broadcast, and other types of media. FDA is particularly interested in hearing about research that provides insight into the effect that direct-to-consumer promotion has on the public health. FDA is also interested in research on the groups most affected by direct-to-consumer promotion, including patients, caretakers, physicians, physicians' assistants, nurses, pharmacists, managed care organizations, and insurers. Meeting Date: September 22 and 23, 2003 Meeting Name: Direct-To-Consumer Promotion Location: National
Transportation Safety Board Boardroom and Conference
Center Time: 9:00 a.m. - 5:00 p.m. Federal Register Notice of Public Meeting [text] [PDF] Meeting Transcripts Contact for Meeting Information: Rose Cunningham, telephone: (301) 594-5468, Fax: (301) 594-5493, email: cunninghamr@cder.fda.gov Persons interested in presenting research should send requests and abstracts in writing to the Dockets Management Division (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852, by close of business August 29, 2003. Please see the Federal Register notice for further instructions. Directions to the NTSB Conference Center from METRO:
Date created: August 11, 2003, Updated: November 10, 2003 |
|
|
||||||
 | ||||||
|
||||||